Summary
Reneo Pharmaceuticals was a clinical-stage company focused on developing therapies for rare genetic mitochondrial diseases and orphan metabolic diseases.
Deals Overview
Senior Management
Mike Grey
Executive Chairman and Founder
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite